J. P. Kampmann

1.7k total citations
27 papers, 1.1k citations indexed

About

J. P. Kampmann is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J. P. Kampmann has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J. P. Kampmann's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical studies and practices (5 papers) and Thyroid Disorders and Treatments (4 papers). J. P. Kampmann is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical studies and practices (5 papers) and Thyroid Disorders and Treatments (4 papers). J. P. Kampmann collaborates with scholars based in Denmark, Germany and Spain. J. P. Kampmann's co-authors include J. Mølholm Hansen, K. Siersbæk‐Nielsen, M. Kristensen, L. Skovsted, J. Mølholm Hansen, Klaus Johansen, Jens Hansen, Henrik B. Mortensen, K. Johansen and A. Nyboe Andersen and has published in prestigious journals such as The Lancet, JAMA and The Journal of Infectious Diseases.

In The Last Decade

J. P. Kampmann

26 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. P. Kampmann Denmark	15	268	192	192	179	134	27	1.1k
J. Mølholm Hansen Denmark	12	185 0.7×	179 0.9×	145 0.8×	179 1.0×	77 0.6×	17	875
D. H. Lawson United Kingdom	22	142 0.5×	177 0.9×	221 1.2×	157 0.9×	200 1.5×	52	1.5k
Charles E. Halstenson United States	22	98 0.4×	374 1.9×	250 1.3×	254 1.4×	91 0.7×	53	1.3k
Jens P. Kampmann Denmark	21	262 1.0×	63 0.3×	304 1.6×	238 1.3×	208 1.6×	71	1.5k
John A. Opsahl United States	17	129 0.5×	228 1.2×	189 1.0×	121 0.7×	72 0.5×	48	1.1k
N Pozet France	20	93 0.3×	259 1.3×	163 0.8×	112 0.6×	62 0.5×	86	1.1k
R. Verberckmoes Belgium	17	69 0.3×	235 1.2×	133 0.7×	102 0.6×	82 0.6×	50	891
Ingegerd Odar‐Cederlöf Sweden	23	98 0.4×	260 1.4×	256 1.3×	390 2.2×	167 1.2×	53	1.7k
Edward T. Zawada United States	18	159 0.6×	164 0.9×	111 0.6×	76 0.4×	65 0.5×	88	1.1k
Michel Andréjak France	22	179 0.7×	201 1.0×	219 1.1×	135 0.8×	117 0.9×	115	1.6k

Countries citing papers authored by J. P. Kampmann

Since Specialization

Citations

This map shows the geographic impact of J. P. Kampmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Kampmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Kampmann more than expected).

Fields of papers citing papers by J. P. Kampmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Kampmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Kampmann. The network helps show where J. P. Kampmann may publish in the future.

Co-authorship network of co-authors of J. P. Kampmann

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Kampmann. A scholar is included among the top collaborators of J. P. Kampmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Kampmann. J. P. Kampmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bjarnason, N. H., et al.. (2006). Optimizing Lithium Dosing in Hemodialysis. Therapeutic Drug Monitoring. 28(2). 262–266. 9 indexed citations

Melander, A., Pietro Folino-Gallo, T Walley, et al.. (2006). Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia. 49(9). 2024–2029. 32 indexed citations

Kampmann, J. P., et al.. (2003). Process control in intensive care-an integrated working place. 1582–1583.

Levin, Danielle, et al.. (2002). Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication. British Journal of Clinical Pharmacology. 53(3). 312–317. 43 indexed citations

Viby‐Mogensen, J., Doris Østergaard, F. Donati, et al.. (2000). Pharmacokinetic studies of neuromuscular blocking agents: Good Clinical Research Practice (GCRP). Acta Anaesthesiologica Scandinavica. 44(10). 1169–1190. 36 indexed citations

Bonde, Jan, et al.. (1994). Drug interactions with intravenous and local anaesthetics. Acta Anaesthesiologica Scandinavica. 38(1). 15–29. 13 indexed citations

Bonde, Jan, et al.. (1993). Drug interactions with inhalational anaesthetics. Acta Anaesthesiologica Scandinavica. 37(3). 231–244. 11 indexed citations

Kampmann, J. P., et al.. (1991). Connection of electronic medical devices in ICU according to the standard ‘MIB’. International journal of clinical monitoring and computing. 8(3). 163–166. 3 indexed citations

Kampmann, J. P.. (1988). Elements of planning in the area of computerized intensive care. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 1789–1790 vol.4. 1 indexed citations

10.

Kampmann, J. P.. (1987). Pharmacokinetics of Various Preparations of Organic Nitrates. Drugs. 33(Supplement 4). 5–8. 14 indexed citations

11.

Bonde, Jan, Niels Graudal, L. E. Pedersen, et al.. (1986). Kinetics of disopyramide in decreased hepatic function. European Journal of Clinical Pharmacology. 31(1). 73–77. 8 indexed citations

12.

Johansen, K., et al.. (1982). Excretion of methimazole in human milk. European Journal of Clinical Pharmacology. 23(4). 339–341. 58 indexed citations

13.

Kampmann, J. P., et al.. (1980). PROPYLTHIOURACIL IN HUMAN MILK Revision of a Dogma. The Lancet. 315(8171). 736–738. 101 indexed citations

14.

Kristensen, M., J. Mølholm Hansen, J. P. Kampmann, et al.. (1974). DRUG ELIMINATION AND RENAL FUNCTION. The Journal of Clinical Pharmacology. 14(5-6). 307–308. 19 indexed citations

15.

Kampmann, J. P. & L. Skovsted. (1974). The Pharmacokinetics of Propylthiouracil. Acta Pharmacologica et Toxicologica. 35(5). 361–369. 46 indexed citations

16.

Kampmann, J. P., et al.. (1974). [Dosage regime for kanamycin, gentamicin and digoxin. Presentation of a slide-rule for the calculation of creatinine clearance and doses of drugs].. PubMed. 137(1). 1–6. 2 indexed citations

17.

Kampmann, J. P.. (1973). Serum Creatinine and Drug Half-Lives. JAMA. 223(2). 193–193. 2 indexed citations

18.

Kampmann, J. P., et al.. (1972). Effect of some drugs on penicillin half‐life in blood. Clinical Pharmacology & Therapeutics. 13(4). 516–519. 38 indexed citations

19.

Siersbæk‐Nielsen, K., J. Mølholm Hansen, J. P. Kampmann, & M. Kristensen. (1971). RAPID EVALUATION OF CREATININE CLEARANCE. The Lancet. 297(7709). 1133–1134. 274 indexed citations

20.

Hansen, Jens, et al.. (1970). RENAL EXCRETION OF DRUGS IN THE ELDERLY. The Lancet. 295(7657). 1170–1170. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact